Proton Pump Inhibitor–Associated Hypomagnesemia: What Do FDA Data Tell Us?
BACKGROUND: Proton pump inhibitors (PPIs) are a class of medications indicated for the treatment of gastric acid–related diseases. Hypomagnesemia is a rare but serious adverse effect of PPIs. OBJECTIVE: To address the association between the use of different PPIs and hypomagnesemia by examining the...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Harvey Whitney Books
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/46050 |